CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Scabies - Management
What are the adverse effects of topical corticosteroids?
- Mildly and moderately potent topical corticosteroids used for short periods are rarely associated with adverse effects.
- Skin atrophy is much more likely with potent and very potent topical corticosteroids.
- There is little risk of skin thinning with mild-to-moderately potent topical corticosteroids when used for up to 4 weeks [DTB, 2003].
© NHS Institute for Innovation and Improvement